Biologicals

This page is still in development however you may find the following links from Crohn's and Colitis UK useful;

Biologicals are a group of different compounds which have been synthesised, often from or resembling specific proteins found within living organisms. They are usually targeted at specific biological processes. In the UK their use is generally restricted to patients with moderate to severe inflammatory bowel disease. This is in part because of their potential side-effects, in part because of their considerable cost (often thousands of pounds per year.

​

Adalimumab

https://www.crohnsandcolitis.org.uk/about-crohns-and-colitis/publications/adalimumab

​

Golimumab

https://www.crohnsandcolitis.org.uk/about-crohns-and-colitis/publications/golimumab

​

Infliximab

https://www.crohnsandcolitis.org.uk/about-crohns-and-colitis/publications/infliximab

​

Tofacitinib

https://www.crohnsandcolitis.org.uk/about-crohns-and-colitis/publications/tofacitinib

​

Ustekinumab

https://www.crohnsandcolitis.org.uk/about-crohns-and-colitis/publications/ustekinumab

​

Vedolizumab

https://www.crohnsandcolitis.org.uk/about-crohns-and-colitis/publications/vedolizumab